Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy

Gabriel Nussbaum, Wendy Cleare, Arturo Casadevall, Matthew D. Scharff, Philippe Valadon

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Monoclonal antibodies (mAbs) to the polysaccharide capsule of Cryptococcus neoformans can prolong survival in mice. However, the properties of antibodies that mediate protection are not fully understood. The IgM mAbs 12A1 and 13F1 originated from the same B cell and differ only by somatic mutations in their variable regions; yet mAb 12A1 protects against serotype D infection, while mAb 13F1 does not. Phage peptide display libraries were used to analyze the fine specificity of these two mAbs. The selection of distinct peptide motifs from identical libraries confirmed that mAbs 12A1 and 13F1 bound to two distinct epitopes. Immunofluorescence and immunoelectron microscopy studies revealed differences in antibody localization within the capsule of serotype D strain; mAb 12A1 bound to the outer rim of the capsule resulting in an annular pattern, whereas mAb 13F1 bound throughout the capsule and had a punctate appearance. The difference in the binding pattern of mAb 12A1 and 13F1 was not observed on serotype A organisms, where both mAbs bound to the capsule with an annular fluorescence pattern. The fluorescence pattern of binding correlated with protective efficacy; mAb 13F1 prolonged survival of mice infected with the J11 serotype A strain (annular fluorescence), but not serotype D strains (punctate pattern). Annular binding, but not punctate binding, was associated with increased opsonic efficacy for phagocytosis of C. neoformans by J774.16 macrophage-like cells. The correlation between capsular binding pattern, opsonic activity, and ability to prolong survival suggests that the efficacy of anticryptococcal antibodies is dependent upon where they bind in the polysaccharide capsule.

Original languageEnglish (US)
Pages (from-to)685-694
Number of pages10
JournalJournal of Experimental Medicine
Volume185
Issue number4
DOIs
StatePublished - Feb 17 1997

Fingerprint

Cryptococcus neoformans
Capsules
Epitopes
Monoclonal Antibodies
Antibodies
Fluorescence
Polysaccharides
Peptide Library
Immunoelectron Microscopy
Fluorescence Microscopy
Phagocytosis
Libraries
Immunoglobulin M
B-Lymphocytes
Macrophages
Serogroup
Peptides
Mutation
Infection

ASJC Scopus subject areas

  • Immunology

Cite this

Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. / Nussbaum, Gabriel; Cleare, Wendy; Casadevall, Arturo; Scharff, Matthew D.; Valadon, Philippe.

In: Journal of Experimental Medicine, Vol. 185, No. 4, 17.02.1997, p. 685-694.

Research output: Contribution to journalArticle

Nussbaum, Gabriel ; Cleare, Wendy ; Casadevall, Arturo ; Scharff, Matthew D. ; Valadon, Philippe. / Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. In: Journal of Experimental Medicine. 1997 ; Vol. 185, No. 4. pp. 685-694.
@article{0c84b98029f449e6b78a5d8eb43e7e1c,
title = "Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy",
abstract = "Monoclonal antibodies (mAbs) to the polysaccharide capsule of Cryptococcus neoformans can prolong survival in mice. However, the properties of antibodies that mediate protection are not fully understood. The IgM mAbs 12A1 and 13F1 originated from the same B cell and differ only by somatic mutations in their variable regions; yet mAb 12A1 protects against serotype D infection, while mAb 13F1 does not. Phage peptide display libraries were used to analyze the fine specificity of these two mAbs. The selection of distinct peptide motifs from identical libraries confirmed that mAbs 12A1 and 13F1 bound to two distinct epitopes. Immunofluorescence and immunoelectron microscopy studies revealed differences in antibody localization within the capsule of serotype D strain; mAb 12A1 bound to the outer rim of the capsule resulting in an annular pattern, whereas mAb 13F1 bound throughout the capsule and had a punctate appearance. The difference in the binding pattern of mAb 12A1 and 13F1 was not observed on serotype A organisms, where both mAbs bound to the capsule with an annular fluorescence pattern. The fluorescence pattern of binding correlated with protective efficacy; mAb 13F1 prolonged survival of mice infected with the J11 serotype A strain (annular fluorescence), but not serotype D strains (punctate pattern). Annular binding, but not punctate binding, was associated with increased opsonic efficacy for phagocytosis of C. neoformans by J774.16 macrophage-like cells. The correlation between capsular binding pattern, opsonic activity, and ability to prolong survival suggests that the efficacy of anticryptococcal antibodies is dependent upon where they bind in the polysaccharide capsule.",
author = "Gabriel Nussbaum and Wendy Cleare and Arturo Casadevall and Scharff, {Matthew D.} and Philippe Valadon",
year = "1997",
month = "2",
day = "17",
doi = "10.1084/jem.185.4.685",
language = "English (US)",
volume = "185",
pages = "685--694",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "4",

}

TY - JOUR

T1 - Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy

AU - Nussbaum, Gabriel

AU - Cleare, Wendy

AU - Casadevall, Arturo

AU - Scharff, Matthew D.

AU - Valadon, Philippe

PY - 1997/2/17

Y1 - 1997/2/17

N2 - Monoclonal antibodies (mAbs) to the polysaccharide capsule of Cryptococcus neoformans can prolong survival in mice. However, the properties of antibodies that mediate protection are not fully understood. The IgM mAbs 12A1 and 13F1 originated from the same B cell and differ only by somatic mutations in their variable regions; yet mAb 12A1 protects against serotype D infection, while mAb 13F1 does not. Phage peptide display libraries were used to analyze the fine specificity of these two mAbs. The selection of distinct peptide motifs from identical libraries confirmed that mAbs 12A1 and 13F1 bound to two distinct epitopes. Immunofluorescence and immunoelectron microscopy studies revealed differences in antibody localization within the capsule of serotype D strain; mAb 12A1 bound to the outer rim of the capsule resulting in an annular pattern, whereas mAb 13F1 bound throughout the capsule and had a punctate appearance. The difference in the binding pattern of mAb 12A1 and 13F1 was not observed on serotype A organisms, where both mAbs bound to the capsule with an annular fluorescence pattern. The fluorescence pattern of binding correlated with protective efficacy; mAb 13F1 prolonged survival of mice infected with the J11 serotype A strain (annular fluorescence), but not serotype D strains (punctate pattern). Annular binding, but not punctate binding, was associated with increased opsonic efficacy for phagocytosis of C. neoformans by J774.16 macrophage-like cells. The correlation between capsular binding pattern, opsonic activity, and ability to prolong survival suggests that the efficacy of anticryptococcal antibodies is dependent upon where they bind in the polysaccharide capsule.

AB - Monoclonal antibodies (mAbs) to the polysaccharide capsule of Cryptococcus neoformans can prolong survival in mice. However, the properties of antibodies that mediate protection are not fully understood. The IgM mAbs 12A1 and 13F1 originated from the same B cell and differ only by somatic mutations in their variable regions; yet mAb 12A1 protects against serotype D infection, while mAb 13F1 does not. Phage peptide display libraries were used to analyze the fine specificity of these two mAbs. The selection of distinct peptide motifs from identical libraries confirmed that mAbs 12A1 and 13F1 bound to two distinct epitopes. Immunofluorescence and immunoelectron microscopy studies revealed differences in antibody localization within the capsule of serotype D strain; mAb 12A1 bound to the outer rim of the capsule resulting in an annular pattern, whereas mAb 13F1 bound throughout the capsule and had a punctate appearance. The difference in the binding pattern of mAb 12A1 and 13F1 was not observed on serotype A organisms, where both mAbs bound to the capsule with an annular fluorescence pattern. The fluorescence pattern of binding correlated with protective efficacy; mAb 13F1 prolonged survival of mice infected with the J11 serotype A strain (annular fluorescence), but not serotype D strains (punctate pattern). Annular binding, but not punctate binding, was associated with increased opsonic efficacy for phagocytosis of C. neoformans by J774.16 macrophage-like cells. The correlation between capsular binding pattern, opsonic activity, and ability to prolong survival suggests that the efficacy of anticryptococcal antibodies is dependent upon where they bind in the polysaccharide capsule.

UR - http://www.scopus.com/inward/record.url?scp=0031035947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031035947&partnerID=8YFLogxK

U2 - 10.1084/jem.185.4.685

DO - 10.1084/jem.185.4.685

M3 - Article

C2 - 9034147

AN - SCOPUS:0031035947

VL - 185

SP - 685

EP - 694

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 4

ER -